FDA Eyes Overhaul Of Risk Disclosure In Pharma Ads
The U.S. Food and Drug Administration announced Friday that it may overhaul regulations surrounding television and radio commercials for pharmaceuticals, saying it's concerned that advertisements describe too many risks and cause...To view the full article, register now.
Already a subscriber? Click here to view full article